| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/28/1997 | US5597576 Tartaric or malic acid diester mixed with oil(s), silica, and/or polyol(s); cosmetics |
| 01/28/1997 | US5597569 Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica |
| 01/28/1997 | US5597562 Oral dosage form of biologically active proteins |
| 01/28/1997 | US5597550 Apparatus and method for administering minerals |
| 01/28/1997 | US5597549 Dissolving film forming surfactant and hydrophilic stabilizer in solvent, freeze drying, contacting with air or gas, mixing with aqueous carrier |
| 01/28/1997 | US5597416 Method of making crystalline sugar and products resulting therefrom |
| 01/28/1997 | CA2181422A1 Fenofibrate galenic formulations and uses thereof |
| 01/28/1997 | CA2068232C Pain controlling composition and method of preparation |
| 01/23/1997 | WO1997002273A1 Warming compounds |
| 01/23/1997 | WO1997002250A1 10-ACYLOXY-10,11-DIHYDRODIBENZ/b,f/AZEPINE-5-CARBOXAMIDES USEFUL FOR TREATING NERVOUS SYSTEM DISORDERS |
| 01/23/1997 | WO1997002046A2 Saccharide conjugates |
| 01/23/1997 | WO1997002038A1 Silver-based pharmaceutical compositions |
| 01/23/1997 | WO1997002031A1 Pharmaceutical amiodarone composition for parenteral delivery |
| 01/23/1997 | WO1997002019A1 Polyester/carboxylic acid composite materials |
| 01/23/1997 | WO1997002018A1 Composition for ph dependent controlled release of active ingredients and methods for producing it |
| 01/23/1997 | WO1997002017A1 Controlled release formulations for poorly soluble drugs |
| 01/23/1997 | WO1997002016A1 Preparations and methods for the treatment of t cell mediated diseases |
| 01/23/1997 | WO1997002014A1 Therapeutic effervescent compositions |
| 01/23/1997 | WO1997002003A2 Compositions |
| 01/23/1997 | WO1996040168A3 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 01/23/1997 | WO1996040089A3 Aerosol drug formulations containing vegetable oils |
| 01/23/1997 | WO1996040073A3 Composition for sustained release of non-aggregated erythropoietin |
| 01/23/1997 | WO1996040072A3 Composition for sustained release of human growth hormone |
| 01/23/1997 | WO1996025947A3 Induction of e-selectin for targetting therapeutic agents |
| 01/23/1997 | DE19526864A1 Hormonpflaster Hormone patches |
| 01/23/1997 | CA2226008A1 Controlled release formulations for poorly soluble drugs |
| 01/23/1997 | CA2225674A1 Therapeutic effervescent compositions |
| 01/23/1997 | CA2222844A1 Water activable adhesive matrix containing amethocaine |
| 01/23/1997 | CA2222372A1 Composition for ph dependent controlled release of active ingredients and methods for producing it |
| 01/22/1997 | EP0754463A2 Stabilized aqueous liquid preparation of blood coagulation factor XIII |
| 01/22/1997 | EP0754461A2 A preservation solution of blood platelets |
| 01/22/1997 | EP0754456A2 Topical application of ST1435 as a contraceptive agent |
| 01/22/1997 | EP0754451A1 Liposome for destroying hiv and cells infected by said virus |
| 01/22/1997 | EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 01/22/1997 | EP0754192A1 Circularly permuted ligands and circularly permuted chimeric molecules |
| 01/22/1997 | EP0754062A1 Product for the enteric supply of food components and process for making it |
| 01/22/1997 | EP0754052A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 01/22/1997 | EP0754047A1 Injectable solutions of dirithromycin |
| 01/22/1997 | EP0754045A1 Halofantrine free base for the treatment of malaria and compositions |
| 01/22/1997 | EP0754036A1 Permanently ionic derivatives of steroid hormones and their antagonists |
| 01/22/1997 | EP0754033A1 Heterofunctional, mucoadhesive dosage form |
| 01/22/1997 | EP0754032A1 Liquid delivery compositions |
| 01/22/1997 | EP0754030A1 Method for stabilizing duocarmycin derivatives |
| 01/22/1997 | EP0696191B1 Particulate vector and pharmaceutical composition containing such vector |
| 01/22/1997 | EP0615450B1 Dimeticon pastilles |
| 01/22/1997 | EP0593656B1 Novel compositions based on taxane class derivatives |
| 01/22/1997 | EP0550737B1 Controlled release verapamil tablet |
| 01/22/1997 | EP0536235B1 Pressurised aerosol compositions |
| 01/22/1997 | EP0481007B1 SLOW RELEASE VEHICLES FOR MINIMIZING SKIN IRRITANCY OF TOPICAL COMPOSITIONS containing retinoids |
| 01/22/1997 | CN1140998A Compositions which inhibit apoptosis, method of purifying the compositions and uses thereof |
| 01/22/1997 | CN1140991A Compositions containing micronized nebivolol |
| 01/22/1997 | CN1140989A Vesicles with controlled release of actives |
| 01/22/1997 | CN1140988A Liquid ophthalmic sustained release delivery system |
| 01/22/1997 | CN1140983A Absorption enhancers for topical pharmaceutical formulations |
| 01/22/1997 | CN1140609A Medicament for nasal administration |
| 01/21/1997 | US5596081 Antibodies and atp or gtp |
| 01/21/1997 | US5595986 Stably storable and readily water soluble composition of cephalosporin for injections |
| 01/21/1997 | US5595980 Contraceptive compositions |
| 01/21/1997 | US5595971 Prolonged release of biologically active polypeptides |
| 01/21/1997 | US5595897 Cationic polymers |
| 01/21/1997 | US5595760 Sustained release of peptides from pharmaceutical compositions |
| 01/21/1997 | US5595747 Slow-releasing compositions containing hydrotalcites which have been intercalated with an organic anion and method of controlling insects and protecting fabric from insects |
| 01/21/1997 | US5595735 Hemostatic thrombin paste composition |
| 01/21/1997 | US5595732 Polyethylene-protein conjugates |
| 01/21/1997 | US5595726 Porphyrin type chromophore conjugated to oligonucleotide, fluorescence, detection of tumors, screening for hiv |
| 01/21/1997 | US5595724 Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
| 01/21/1997 | US5595722 Transforming growth factor-beta activators |
| 01/21/1997 | CA2118133C Aminoguanidine spray drying process |
| 01/21/1997 | CA2098196C Method and systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers |
| 01/21/1997 | CA2039518C Cosmetic gel stick compositions |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001552A1 Triazole antifungal agents |
| 01/16/1997 | WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 01/16/1997 | WO1997001356A1 Cholesterol ester clathrate, water-holding composition, hydrous compositions, cosmetics containing the same, and processes for the preparation thereof |
| 01/16/1997 | WO1997001329A1 New, stable medicinal compositions for generating propellant-free aerosols |
| 01/16/1997 | WO1997001326A1 Stable topical compositions |
| 01/16/1997 | WO1997001324A2 Cosmetic and/or pharmaceutical preparations |
| 01/16/1997 | WO1996036318A3 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application |
| 01/16/1997 | DE19627392A1 Medikament zur Verabreichung durch die Nase Medication to be administered through the nose |
| 01/16/1997 | CA2225444A1 Stable topical compositions |
| 01/16/1997 | CA2198887A1 Cholesterol ester clathrate, water-holding composition, hydrous compositions, cosmetics containing the same, and process for the preparation thereof |
| 01/15/1997 | EP0753523A1 Amino-substituted bisphosphonic acids |
| 01/15/1997 | EP0753341A1 Use of hydrofluorocarbon thiolesters in emulsions, cosmetic or dermatalogical applications |
| 01/15/1997 | EP0753297A1 Lotion |
| 01/15/1997 | EP0753296A2 Oral formulations of S(+)-ibuprofen |
| 01/15/1997 | EP0753295A1 Use of deformable hollow particles against the photoblueing and/or the whitening of a cosmetic and/or dermatologic composition containing titanium oxide pigments |
| 01/15/1997 | EP0753262A2 Coating composition for preparing solid preparations and solid preparations |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0753070A1 Novel nucleic acid/polymer complexes, method for preparing same and use thereof for cell transfection |
| 01/15/1997 | EP0753069A1 Gene delivery fusion proteins |
| 01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
| 01/15/1997 | EP0752885A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 01/15/1997 | EP0752877A1 Stabilized composition for oral administration of peptides |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752866A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 01/15/1997 | EP0752855A1 Use of fatty acid esters as bioadhesive substances |
| 01/15/1997 | EP0752851A1 New pharmaceutical formulation and process |
| 01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
| 01/15/1997 | EP0752848A1 Pharmaceutical excipient having improved compressibility |
| 01/15/1997 | EP0752847A1 Ophthalmic composition with decreased viscosity |